Cargando…

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment

BACKGROUND: The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of cell growth and survival signaling as well transformation induced by multiple tyrosine kinase oncogenes. Since the basal-like and triple-negative breast cancer (BTBC) is characterized by dysregulation of multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hua, Agazie, Yehenew M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359540/ https://www.ncbi.nlm.nih.gov/pubmed/25885600 http://dx.doi.org/10.1186/s12885-015-1131-2

Ejemplares similares

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer
por: Matalkah, Fatimah, et al.
Publicado: (2016)

SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021)

Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects
por: Hartman, Zachary, et al.
Publicado: (2020)

Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes
por: Lade, Dhanaji M., et al.
Publicado: (2023)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
por: Kern, Joseph G., et al.
Publicado: (2022)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

The utilization of basal luteinizing hormone in combination with the basal luteinizing hormone and follicle-stimulating hormone ratio as a diagnostic tool for central precocious puberty in girls
por: Chotipakornkul, Nuntika, et al.
Publicado: (2023)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Sung, Vanessa Y. C., et al.
Publicado: (2021)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

Protein-based immune profiles of basal-like vs. luminal breast cancers
por: Walens, Andrea, et al.
Publicado: (2021)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?
por: Lee, Dong Seong, et al.
Publicado: (2013)

Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis
por: Zhao, Hua, et al.
Publicado: (2018)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
por: Petrelli, Annalisa, et al.
Publicado: (2014)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Isolation and characterization of a new basal-like luminal progenitor in human breast tissue
por: Bhat, Vasudeva, et al.
Publicado: (2019)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for diagnosis of precocious puberty in Korean girls?
por: Lee, Sun Hee, et al.
Publicado: (2013)

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
por: Uva, Paolo, et al.
Publicado: (2018)

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
por: Petrelli, Annalisa, et al.
Publicado: (2019)

The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer
por: Li, Ziyao, et al.
Publicado: (2015)

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits
por: Mohamed, Gadisti Aisha, et al.
Publicado: (2023)

HER2 Stabilizes EGFR and Itself by Altering Autophosphorylation Patterns in a Manner That Overcomes Regulatory Mechanisms and Promotes Proliferative and Transformation Signaling
por: Hartman, Zachary, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q6ue81hc96t1fa7jt9vnuphvit